tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ALLO Stock Latest News

Allogene Therapeutics participates in a conference call with JPMorgan
The FlyAllogene Therapeutics participates in a conference call with JPMorgan
1d ago
ALLO
Allogene Therapeutics: Buy Rating Backed by Promising Pipeline Developments and Strong Financial Position
PremiumRatings
Allogene Therapeutics: Buy Rating Backed by Promising Pipeline Developments and Strong Financial Position
9d ago
ALLO
Allogene Therapeutics price target lowered to $8 from $9 at H.C. Wainwright
PremiumThe Fly
Allogene Therapeutics price target lowered to $8 from $9 at H.C. Wainwright
9d ago
ALLO
Allogene Therapeutics management to meet virtually with Truist
PremiumThe Fly
Allogene Therapeutics management to meet virtually with Truist
10d ago
ALLO
Allogene Therapeutics’ Earnings Call Highlights Progress
PremiumCompany Announcements
Allogene Therapeutics’ Earnings Call Highlights Progress
13d ago
ALLO
Promising Pipeline and Upcoming Data Releases Drive Buy Rating for Allogene Therapeutics
PremiumRatingsPromising Pipeline and Upcoming Data Releases Drive Buy Rating for Allogene Therapeutics
13d ago
ALLO
Allogene upgraded to Outperform from Market Perform at Citizens JMP
Premium
The Fly
Allogene upgraded to Outperform from Market Perform at Citizens JMP
14d ago
ALLO
Promising Developments in Allogene Therapeutics’ Cema-cel Therapy Highlighted by Phase I Data and Upcoming ALPHA3 Trial
Premium
Ratings
Promising Developments in Allogene Therapeutics’ Cema-cel Therapy Highlighted by Phase I Data and Upcoming ALPHA3 Trial
14d ago
ALLO
Promising Potential and Strategic Growth: A Buy Rating for Allogene Therapeutics
PremiumRatings
Promising Potential and Strategic Growth: A Buy Rating for Allogene Therapeutics
14d ago
ALLO
Allogene Therapeutics Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Allogene Therapeutics Reports 2024 Financial Results and Progress
14d ago
ALLO
Allogene Therapeutics reports Q4 EPS (28c), consensus (32c)
PremiumThe Fly
Allogene Therapeutics reports Q4 EPS (28c), consensus (32c)
14d ago
ALLO
Allogene to invest $37.3M in expanded MRD assay pact with Foresight Diagnostics
PremiumThe Fly
Allogene to invest $37.3M in expanded MRD assay pact with Foresight Diagnostics
1M ago
ALLO
ALLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsALLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
ALLO
Short Report: Bearish bets on SunRun hit six-month high
Premium
The Fly
Short Report: Bearish bets on SunRun hit six-month high
1M ago
RUN
ALLO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ALLO
ATYR
Baird ‘encouraged’ by Allogene CAR-T therapy update
PremiumThe Fly
Baird ‘encouraged’ by Allogene CAR-T therapy update
1M ago
ALLO
Airbnb, Moderna report Q4 results: Morning Buzz
PremiumThe Fly
Airbnb, Moderna report Q4 results: Morning Buzz
1M ago
BA
AMD
Allogene publishes data from ALPHA, ALPHA2 trials of cemacabtagene ansegedleucel
PremiumThe Fly
Allogene publishes data from ALPHA, ALPHA2 trials of cemacabtagene ansegedleucel
1M ago
ALLO
Allogene Therapeutics Announces Executive Departure and Transition
PremiumCompany Announcements
Allogene Therapeutics Announces Executive Departure and Transition
2M ago
8K
ALLO
Allogene Therapeutics appoints Beneski as SVP, CTO
PremiumThe FlyAllogene Therapeutics appoints Beneski as SVP, CTO
2M ago
ALLO
Allogene announces FDA cleared IND application for study of ALLO-329
Premium
The Fly
Allogene announces FDA cleared IND application for study of ALLO-329
2M ago
ALLO
Allogene acknowledges passing of founding board member David Bonderman
Premium
The Fly
Allogene acknowledges passing of founding board member David Bonderman
4M ago
ALLO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >